Vaccines Alone Cannot Slow the Evolution of SARS-CoV-2

Area of Science:

• Virology
• Epidemiology
• Computational Biology

Background:

• The emergence of immune-evading SARS-CoV-2 variants challenges a vaccine-only strategy for COVID-19.
• Widespread vaccination is proposed as a method to prevent future immune-evading mutant emergence.

Purpose of the Study:

• To examine the proposition that widespread vaccination is necessary to prevent the emergence of future immune-evading SARS-CoV-2 mutants.
• To assess the impact of vaccination on the emergence of multi-mutation immune escape variants.

Main Methods:

• Stochastic computational modeling of viral transmission and mutation dynamics.
• Analysis of the likelihood of immune escape variant emergence.
• Evaluation of vaccination's impact on variant evolution.

Main Results:

• The transmission rate of intermediate SARS-CoV-2 mutants influences the emergence rate of novel immune-evading variants.
• Vaccination can reduce, but not eliminate, the emergence rate of new variants.
• High population transmission rates, even with repeated vaccination, are insufficient to prevent novel immune-evading strains.

Conclusions:

• Vaccines alone are insufficient to slow the evolution of immune evasion in SARS-CoV-2.
• Reliance solely on vaccination is not a guaranteed strategy to prevent immune-evading strains.
• Vaccinal protection against severe and fatal COVID-19 outcomes is not assured if transmission remains high.